Literature DB >> 15633237

Incidence of HBV variants with a mutation at nt551 among hepatitis B patients in Nanjing and its neighbourhood.

Chun-Ling Ma1, De-Xing Fang, Kun Yao, Fa-Qing Li, Hui-Ying Jin, Su-Qin Li, Wei-Guo Tan.   

Abstract

AIM: To investigate the epidemiology of hepatitis B virus (HBV) strains with a mutation at nt551 in surface gene among hepatitis B patients in Nanjing and its neighbourhood.
METHODS: By using mutation-specific polymerase chain reaction (msPCR) established by our laboratory for amplifying HBV DNAs with a mutation at nt551, 117 serum samples taken from hepatitis B patients were detected.
RESULTS: The results showed that 112 samples were positive for nt551A, 4 samples were positive for nt551G. One sample was positive for nt551T. No nt551C of HBV DNA was found. The incidence of HBsAg mutants with G, C, T, A at nt551 among 117 samples was 3.42%, 0%, 0.85%, 95.73%, respectively.
CONCLUSION: In Nanjing and its neighbourhood, hepatitis B patients are mainly infected with wild genotype HBV. The incidence of mutants with a mutation at nt551 in HBV genome is significantly lower than that in wild genotype HBV DNA (P<0.01). The necessity of adding components of HBsAg mutants to HBV vaccine needs further investigation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15633237      PMCID: PMC4205423          DOI: 10.3748/wjg.v11.i2.299

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

1.  Horizontal transmission of a hepatitis B virus surface antigen mutant.

Authors:  W N Chen; C J Oon; S Koh
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  [Hepatitis B virus gene mutations in the sera of three patients with coexisting hepatitis B surface antigen and anti-surface antibody].

Authors:  N Yukimasa; H Ohkushi; K Fukasawa; K Fukuchi; Y Takagi; K Gomi
Journal:  Rinsho Byori       Date:  2000-02

3.  [A novel stop codon mutation in S gene: the molecular basis of a patient with cryptogenic cirrhosis].

Authors:  Xu Yang; Jianhua Lei; Yonghong Zhang; Hongyu Luo; Li Huang; Yuhuang Zheng; Xiaopeng Tang; Liangyou Li
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2002-03-25

4.  Isolation, characterization and biological significance of hepatitis B virus mutants from serum of a patient with immunologically negative HBV infection.

Authors:  M Schories; T Peters; J Rasenack
Journal:  J Hepatol       Date:  2000-11       Impact factor: 25.083

5.  Genetic alterations in the S gene of hepatitis B virus in patients with acute hepatitis B, chronic hepatitis B and hepatitis B liver cirrhosis before and after liver transplantation.

Authors:  F Rodriguez-Frias; M Buti; R Jardi; V Vargas; J Quer; M Cotrina; M Martell; R Esteban; J Guardia
Journal:  Liver       Date:  1999-06

6.  Analysis of HBs antigen negative variant of hepatitis B virus: unique substitutions, Glu129 to Asp and Gly145 to Ala in the surface antigen gene.

Authors:  T Koyanagi; M Nakamuta; H Sakai; R Sugimoto; M Enjoji; K Koto; H Iwamoto; T Kumazawa; M Mukaide; H Nawata
Journal:  Med Sci Monit       Date:  2000 Nov-Dec

7.  Molecular, immunological and clinical properties of mutated hepatitis B viruses.

Authors:  C Kreutz
Journal:  J Cell Mol Med       Date:  2002 Jan-Mar       Impact factor: 5.310

8.  Acute self-limiting hepatitis B after immunoprophylaxis failure in an infant.

Authors:  Haruki Komatsu; Tomoo Fujisawa; Tsuyoshi Sogo; Atsushi Isozaki; Ayano Inui; Isao Sekine; Makoto Kobata; Yunosuke Ogawa
Journal:  J Med Virol       Date:  2002-01       Impact factor: 2.327

9.  [The study on heterogeneity of hepatitis B virus DNA].

Authors:  Jing Dong; Jun Cheng; Qinhuan Wang; Jingkun Huangfu; Shuangshuang Shi; Guoqing Zhang; Yuan Hong; Li Li; Chongwen Si
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2002-01-25

10.  Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues.

Authors:  S Zhong; J Y Chan; W Yeo; J S Tam; P J Johnson
Journal:  J Viral Hepat       Date:  1999-05       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.